v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 110,830 $ 153,191
Accounts receivable, net 121,486 127,312
Inventory, net 75,411 74,060
Other current assets and prepaid expenses 98,691 39,962
Total current assets 406,418 394,525
Property, plant and equipment, net 80,853 82,879
Intangible assets, net 803,616 823,520
In-process research and development 195,000 195,000
Goodwill 597,380 595,851
Investments 41,231 28,080
Operating lease right-of-use assets 36,832 38,725
Other assets 8,340 8,679
Total assets 2,169,670 2,167,259
Current liabilities:    
Accounts payable 80,503 66,993
Accrued expenses 106,058 98,269
Current maturities of operating leases 11,490 11,628
Current portion of convertible notes 0 3,050
Current portion of lines of credit and notes payable 24,371 33,540
Total current liabilities 222,422 213,480
Operating lease liabilities 26,462 27,963
Long term portion of convertible notes 211,328 210,371
Deferred tax liabilities 129,668 126,426
Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit 27,980 27,371
Total long-term liabilities 395,438 392,131
Total liabilities 617,860 605,611
Equity:    
Common Stock - $0.01 par value, 1,000,000,000 shares authorized; 781,306,164 and 781,306,164 shares issued at March 31, 2023 and December 31, 2022, respectively 7,813 7,813
Treasury Stock - 8,655,082 shares at March 31, 2023 and December 31, 2022, respectively (1,791) (1,791)
Additional paid-in capital 3,424,589 3,421,872
Accumulated other comprehensive loss (37,611) (43,323)
Accumulated deficit (1,841,190) (1,822,923)
Total shareholders’ equity 1,551,810 1,561,648
Total liabilities and equity $ 2,169,670 $ 2,167,259

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL